S. ŞANLIOĞLU Et Al. , "A CTLA-4 exon 1+49 A/A genotype is linked to the clinical progression of systemic lupus erythematosus in patients," 13th Annual Congress of European Society of Gene Therapy , Prague, Czech Republic, pp.76, 2005
ŞANLIOĞLU, S. Et Al. 2005. A CTLA-4 exon 1+49 A/A genotype is linked to the clinical progression of systemic lupus erythematosus in patients. 13th Annual Congress of European Society of Gene Therapy , (Prague, Czech Republic), 76.
ŞANLIOĞLU, S., ULKER, M., TERZİOĞLU, M. E., & YAZISIZ, V., (2005). A CTLA-4 exon 1+49 A/A genotype is linked to the clinical progression of systemic lupus erythematosus in patients . 13th Annual Congress of European Society of Gene Therapy (pp.76). Prague, Czech Republic
ŞANLIOĞLU, SALİH Et Al. "A CTLA-4 exon 1+49 A/A genotype is linked to the clinical progression of systemic lupus erythematosus in patients," 13th Annual Congress of European Society of Gene Therapy, Prague, Czech Republic, 2005
ŞANLIOĞLU, SALİH Et Al. "A CTLA-4 exon 1+49 A/A genotype is linked to the clinical progression of systemic lupus erythematosus in patients." 13th Annual Congress of European Society of Gene Therapy , Prague, Czech Republic, pp.76, 2005
ŞANLIOĞLU, S. Et Al. (2005) . "A CTLA-4 exon 1+49 A/A genotype is linked to the clinical progression of systemic lupus erythematosus in patients." 13th Annual Congress of European Society of Gene Therapy , Prague, Czech Republic, p.76.
@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU Et Al. }, title={A CTLA-4 exon 1+49 A/A genotype is linked to the clinical progression of systemic lupus erythematosus in patients}, congress name={13th Annual Congress of European Society of Gene Therapy}, city={Prague}, country={Czech Republic}, year={2005}, pages={76} }